Literature DB >> 19898199

Regulatory T cells in transplantation: transferring mouse studies to the clinic.

Elaine Long1, Kathryn J Wood.   

Abstract

Switching the balance from rejection of major histocompatibility-mismatched grafts toward long-term tolerance of donor grafts, with the need for minimal immunosuppressive drugs, is a major transplantation goal. Regulatory T cells (Treg) can induce and maintain antigen-specific immune tolerance and facilitate allogeneic graft survival successfully in animals. This review will focus on the valuable insights experimental mouse models have given us into the effects of currently used immunosuppressive reagents on Treg, the Treg transcription factor forkhead box P3, and strategies to expand or induce alloantigen-reactive Treg in vivo and in vitro. These have facilitated the translation of strategies for promoting transplantation tolerance towards a new clinical era.

Entities:  

Mesh:

Year:  2009        PMID: 19898199     DOI: 10.1097/TP.0b013e3181bb7913

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  23 in total

Review 1.  CD4(+)Foxp3(+) regulatory T cell therapy in transplantation.

Authors:  Qizhi Tang; Jeffrey A Bluestone; Sang-Mo Kang
Journal:  J Mol Cell Biol       Date:  2011-12-14       Impact factor: 6.216

2.  Co-inhibitory molecules: Controlling the effectors or controlling the controllers?

Authors:  Govindarajan Thangavelu; Christa Smolarchuk; Colin C Anderson
Journal:  Self Nonself       Date:  2010-02-16

Review 3.  Do cannabinoids have a therapeutic role in transplantation?

Authors:  Mitzi Nagarkatti; Sadiye Amcaoglu Rieder; Venkatesh L Hegde; Shunsuke Kanada; Prakash Nagarkatti
Journal:  Trends Pharmacol Sci       Date:  2010-06-28       Impact factor: 14.819

4.  Attenuation of donor-reactive T cells allows effective control of allograft rejection using regulatory T cell therapy.

Authors:  K Lee; V Nguyen; K-M Lee; S-M Kang; Q Tang
Journal:  Am J Transplant       Date:  2013-11-13       Impact factor: 8.086

5.  Regulatory T Cells for the Induction of Transplantation Tolerance.

Authors:  Weitao Que; Xiao-Kang Li
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 6.  Regulatory T cells for tolerance therapy: revisiting the concept.

Authors:  Christian Leguern
Journal:  Crit Rev Immunol       Date:  2011       Impact factor: 2.214

7.  Inhibiting CXCR3-dependent CD8+ T cell trafficking enhances tolerance induction in a mouse model of lung rejection.

Authors:  Edward Seung; Josalyn L Cho; Tim Sparwasser; Benjamin D Medoff; Andrew D Luster
Journal:  J Immunol       Date:  2011-05-09       Impact factor: 5.422

8.  Foxp3+-inducible regulatory T cells suppress endothelial activation and leukocyte recruitment.

Authors:  Elena Maganto-García; De-Xiu Bu; Margarite L Tarrio; Pilar Alcaide; Gail Newton; Gabriel K Griffin; Kevin J Croce; Francis W Luscinskas; Andrew H Lichtman; Nir Grabie
Journal:  J Immunol       Date:  2011-08-26       Impact factor: 5.422

9.  Prevention of acute liver allograft rejection by IL-10-engineered mesenchymal stem cells.

Authors:  J Niu; W Yue; Y Song; Y Zhang; X Qi; Z Wang; B Liu; H Shen; X Hu
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

10.  Tolerogenic Donor-Derived Dendritic Cells Risk Sensitization In Vivo owing to Processing and Presentation by Recipient APCs.

Authors:  Lesley A Smyth; Kulachelvy Ratnasothy; Aurelie Moreau; Sally Alcock; Pervinder Sagoo; Lucy Meader; Yakup Tanriver; Matthew Buckland; Robert Lechler; Giovanna Lombardi
Journal:  J Immunol       Date:  2013-03-27       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.